ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

2
ACSIS: Reperfusion therapies in patients with STEAMI and renal failure Dragu R et al. Am J Cardiol 2006; 97:1142- 1145. Therapy Patients, n (%) Thrombolytic therapy 24 (18.2) Primary PCI 35 (26.5) No reperfusion therapy 73 (55.3)

description

ACSIS: Reperfusion therapies in patients with STEAMI and renal failure. Dragu R et al. Am J Cardiol 2006; 97:1142-1145. 30-day crude mortality by reperfusion strategy. Dragu R et al. Am J Cardiol 2006; 97:1142-1145. - PowerPoint PPT Presentation

Transcript of ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

Page 1: ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

Dragu R et al. Am J Cardiol 2006; 97:1142-1145.

Therapy Patients, n (%)

Thrombolytic therapy

24 (18.2)

Primary PCI 35 (26.5)

No reperfusion therapy

73 (55.3)

Page 2: ACSIS: Reperfusion therapies in patients with STEAMI and renal failure

30-day crude mortality by reperfusion strategy Outcome Thrombolysis Primary

PCINo treatment

p

Crude mortality rate (%)

8.3 40.0 29.7 0.03

Dragu R et al. Am J Cardiol 2006; 97:1142-1145.